Abstract
Fucosidosis is a rare lysosomal storage disease caused by α-fucosidase deficiency, which leads to progressive neurological deterioration and death. Hematopoietic stem cell transplantation is the best curative therapy if performed during the early stages of disease. We report two fucosidosis patients with brain abnormalities and the challenge faced in their management. The first patient received supportive therapy and the second one firstly underwent unrelated donor umbilical cord blood transplantation. After a period of follow-up, we found neurological symptoms were worsening day by day on patient1. By contrast, patient2 who received cord blood transplantation acquired clinical neurologic improvement in response to normalization of deficient enzymatic activity. This report indicates that hematopoietic transplant could reduce the severity and retard the progression of clinical neurological deterioration. Umbilical cord blood transplantation is a novel approach for treating fucosidosis patients who lack suitable bone morrow donors.
This is a preview of subscription content, log in via an institution to check access.
References
Ballen KK, Koreth J, Chen YB et al (2012) Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Blood 119:1972–1980
Bharati A, Higgins C, Ellis I, Wraith J (2007) Fucosidosis: a therapeutic challenge. Pediatr Dermatol 24:442–443
Borrone C, Gatti R, Durand P (1974) Fucosidosis: clinical, biochemical, immunologic and genetic studies in two new cases. J Pediatr 84:727–730
Fletcher JL, Taylor RM (2016) Therapy development for the lysosomal storage disease fucosidosis using the canine animal model. Pediatr Endocrinol Rev 13:697–706
Kondagari GS, King BM, Thomson PC et al (2011) Treatment of canine fucosidosis by intracisternal enzyme infusion. Exp Neurol 230:218–226
Lin SP, Chang JH, de la Cadena MP et al (2007) Mutation identification and characterization of a Taiwanese patient with fucosidosis. J Hum Genet 52:553–556
Martin PL, Carter SL, Kernan NA et al (2006) Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 12:184–194
Miano M, Lanino E, Gatti R et al (2001) Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation. Bone Marrow Transplant 27:747–751
Miranda CO, Brites P, Mendes Sousa M et al (2013) Advances and pitfalls of cell therapy in metabolic leukodystrophies. Cell Transplant 22:189–204
Taylor RM, Farrow BR, Stewart GJ, Healy PJ (1986) Enzyme replacement in nervous tissue after allogeneic bone-marrow transplantation for fucosidosis in dogs. The Lancet 328:772–774
Vellodi A, Cragg H, Winchester B et al (1995) Allogeneic bone marrow transplantation for fucosidosis. Bone Marrow Transplant 15:153–158
Whitley CB, Ramsay NKC, Kersey JH, Krivit W (1986) Bone marrow transplantation in Hurler syndrome: assessment of metabolic correction. In: Krivit W, Paul NP (eds) Bone marrow transplantation for treatment of lysosomal storage diseases, vol 22. March of Dimes, New York, p 7–24
Willems P, Gatti R, Darby JK, Romeo G et al (1991) Fucosidosis revisited: a review of 77 patients. Am J Med Genet 38:111–131
Acknowledgements
This work was supported by the National Natural Science Foundation of China (No.81671119) and the Major Medical Collaboration and Innovation Program of Guangzhou Science Technology and Innovation Commission (No.201604020020).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Minyan Jiang and Sha Liu are first author
Rights and permissions
About this article
Cite this article
Jiang, M., Liu, S., Jiang, H. et al. Brain abnormalities in fucosidosis: transplantation or supportive therapy?. Metab Brain Dis 32, 317–320 (2017). https://doi.org/10.1007/s11011-017-9968-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-017-9968-5